• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email
    SC 13G/A 1 achc13gasep24.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) ACADIA HEALTHCARE CO INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 00404A109 (CUSIP NUMBER) September 30, 2024 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 6,107,600 6. Shared Voting Power* 0 7. Sole Dispositive Power* 6,121,895 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 6,121,895 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 6.6% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: ACADIA HEALTHCARE CO INC Item 1(b) Address of Issuer's Principal Executive Offices: 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN, TENNESSEE 37067 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 00404A109 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: November 14, 2024 Signature: /s/ Ellen York Name & Title: Ellen York, Vice President 09/30/2024
    Get the next $ACHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    4/25/2024$70.00Sell → Hold
    Deutsche Bank
    3/6/2024$100.00Overweight
    Barclays
    4/21/2023$83.00Neutral
    Cantor Fitzgerald
    4/20/2023$75.00 → $63.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Acadia Healthcare to Participate in BofA Securities Health Care Conference

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 1:20 p.m. Central Time / 11:20 a.m. Pacific Time on Wednesday, May 14th, 2025. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading provider of behavi

      5/8/25 11:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2033

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) (the "Company" or "Acadia") announced today the pricing of its private offering (the "Offering") of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the "Notes"), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customary closing and market conditions. The Company intends to use the proceeds from the Offering to prepay the outstanding borrowings under its existing senior secured revolving line of credit. The Notes will bear interest at the rate of

      3/6/25 4:05:00 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/14/24 1:28:32 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/12/24 9:50:14 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

      SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

      11/8/24 10:52:39 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Dixon Heather Brianne was granted 43,823 shares, increasing direct ownership by 56% to 122,499 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 6:02:50 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • EVP, GC and Secretary Farley Brian was granted 38,606 shares, increasing direct ownership by 112% to 73,022 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 5:57:46 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Chief Operating Officer Khan Nasser was granted 30,676 shares, increasing direct ownership by 121% to 55,996 units (SEC Form 4)

      4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

      5/7/25 5:56:52 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Acadia Healthcare Company Inc.

      DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      4/10/25 5:03:34 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • SEC Form DEF 14A filed by Acadia Healthcare Company Inc.

      DEF 14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      4/10/25 5:02:30 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Company Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

      3/10/25 5:14:33 PM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Acadia Healthcare downgraded by Barclays with a new price target

      Barclays downgraded Acadia Healthcare from Overweight to Equal Weight and set a new price target of $35.00 from $43.00 previously

      2/28/25 7:39:54 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Acadia Healthcare from Sector Weight to Overweight and set a new price target of $70.00

      1/7/25 7:39:01 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Acadia Healthcare from Hold to Buy and set a new price target of $75.00 from $45.00 previously

      12/12/24 8:38:21 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Financials

    Live finance-specific insights

    See more
    • Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

      Acadia Healthcare (NASDAQ:ACHC) ("Acadia" or the "Company") today announced that it will release its first quarter 2025 financial results on Monday, May 12, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. The Company also announced that on April 18, 2025, Heather Dixon, the Company's Chief Financial Officer, will take a brief medical leave to recover from a planned medical procedure. Duri

      4/16/25 8:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Reports Fourth Quarter 2024 Results

      Company Provides Full Year and First Quarter 2025 Guidance, Announces $300 Million Share Repurchase Authorization Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjusted income attributab

      2/27/25 4:05:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2024 Earnings Release

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2024, Acadia operated a network of 260 behavioral

      2/6/25 11:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A ribbon-cutting ceremony was held today to mark its grand opening. The first patient admissions are expected to follow in the coming days as the hospital completes its final preparations to provide care for those in need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411986178/en/Acadia Healthcare hosts ribbon-cutting ceremony on April 11, 2024, for its new behavioral health hospital in Mesa, Arizona. The new hospital, named Agave R

      4/11/24 2:16:00 PM ET
      $ACHC
      Medical Specialities
      Health Care
    • Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer

      Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced the appointment of Dr. Stephanie Eken as the Company's new chief medical officer. Dr. Eken is a psychiatrist with more than two decades of experience across the spectrum of behavioral health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404108920/en/Acadia Healthcare Appoints Dr. Stephanie Eken as Chief Medical Officer (Photo: Business Wire) "Acadia is thrilled to welcome Dr. Eken as our new chief medical officer," said Chris Hunter, Chief Executive Officer of Acadia Healthcare. "Her experience and expertise will help Acadia set the standard for care across the i

      4/4/24 9:00:00 AM ET
      $ACHC
      Medical Specialities
      Health Care
    • Henry Ford Health and Acadia Healthcare Appoint Emily Sexton as CEO of New Henry Ford Behavioral Health Hospital

      Henry Ford Health, one of the nation's premier academic and integrated health systems, and Acadia Healthcare, the nation's largest stand-alone behavioral healthcare company, today announced the appointment of Emily Sexton as Chief Executive Officer of Henry Ford Behavioral Health Hospital, the new 192-bed inpatient behavioral health hospital being built through a joint venture partnership between Henry Ford and Acadia in West Bloomfield, Michigan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220715559/en/Henry Ford Health and Acadia Healthcare announced the appointment of Emily Sexton as Chief Executive Officer of Henry For

      2/20/24 1:00:00 PM ET
      $ACHC
      Medical Specialities
      Health Care